Bravo on MSN1d
Karen Huger Had a Surprising Response to Ozempic Questions: "Preventative Care"
Karen Huger revealed whether she's using Ozempic, explaining she's using a medication for a reason other than weight loss. Learn more.
No, No, No, Ozempic? RFK Jr.’s Plan to Ban Big Pharma Ads Could Hit TV Networks Hard
Trump’s pick to lead the Health Department is targeting a multibillion-dollar ad market that’s one of the biggest spenders on ...
RFK Jr’s call to ban TV drug advertisements revives talks of price transparency
RFK Jr.'s call to ban TV advertisements for prescription drugs reignited support for a bipartisan bill that would mandate the retail prices of drugs be included in TV ads.
The Associated Press on MSN12d
US 'notorious markets' report warns of risks from online pharmacies
BANGKOK — Nearly all of the world’s 35,000 online pharmacies are being run illegally and consumers who use them risk getting ...
Jacobin on MSN8d
Drug Ads Misinform Patients and Raise Health Care Costs
Direct-to-consumer drug ads are prohibited in almost all countries besides the US. By leading doctors to prescribe unnecessary and more expensive treatments at the request of their patients, they also ...
RFK Jr. wants to ban drug ads on TV. It won't be easy
President-elect Donald Trump’s administration is expected to push to ban TV advertising for prescription drugs — but Big ...
NBC News7d
FDA bans Red Dye No. 3, artificial coloring used in beverages, candy and other foods
BREAKING: FDA bans Red Dye No. 3, artificial coloring used in food and drinks Profile Sections Local tv ... drug pricing and health care. He previously covered the biotech and pharmaceutical ...
MM&M5d
Skyrizi claims year-end TV ad crown among Rx, OTC pharma brands
Skyrizi had an estimated national TV ad spend of $367.7 million — the highest ad spend of any brand in the top 10.
Business Insider5d
Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations
AbbVie and Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group, announced an option to license agreement to develop SIM0500, an investigational new drug candidate. SIM0500 is currently ...